Response to Brodehl et al.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Minoche AE, Horvat C, Johnson R, Gayevskiy V, Morton SU, Drew AP, et al. Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy. Genet Med. 2018 Jul 2; https://doi.org/10.1038/s41436-018-0084-7

  2. 2.

    Brodehl A, Ebbinghaus H, Gaertner-Rommel A, Stanasiuk C, Klauke B, Milting H. Functional analysis of DES-p.L398P and RBM20-p.R636C. Genet Med. https://doi.org/10.1038/s41436-018-0291-2. Accessed 28 September 2018.

  3. 3.

    Brauch KM, Karst ML, Herron KJ, et al. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol. 2009;54:930–941.

  4. 4.

    Li D, Morales A, Gonzalez-Quintana J, Norton N, Siegfried JD, Hofmeyer M, et al. Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy. Clin Transl Sci. 2010;3:90–97.

  5. 5.

    Wyles SP, Li X, Hrstka SC, et al. Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells. Hum Mol Genet. 2016;25:254–265.

  6. 6.

    Murayama R, Kimura-Asami M, Togo-Ohno M, et al. Phosphorylation of the RSRSP stretch is critical for splicing regulation by RNA-binding protein 20 (RBM20) through nuclear localization. Sci Rep. 2018;8:8970.

  7. 7.

    Tse HF, Ho JC, Choi SW, Lee YK, Butler AW, Ng KM, et al. Patient-specific induced pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. Hum Mol Genet. 2013;22:1395–1403.

  8. 8.

    Brodehl A, Dieding M, Biere N, Unger A, Klauke B, Walhorn V, et al. Functional characterization of the novel DES mutation p.L136P associated with dilated cardiomyopathy reveals a dominant filament assembly defect. J Mol Cell Cardiol. 2016;91:207–214.

  9. 9.

    Horvat C, Johnson R, Lam L, et al. A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy. Genet Med. 2018 Jun 11; https://doi.org/10.1038/s41436-018-0036-2

  10. 10.

    Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424.

Download references

Acknowledgements

This work was undertaken as part of the Cardiogenomics Project, and would not have been possible without the support of John Schubert, the Kinghorn Foundation, Garvan Foundation, and the Victor Chang Cardiac Research Institute. Funding support was also received from the NSW Office of Health and Medical Research Collaborative Grants Program, National Health and Medical Research Council (D.F., C.S.), Estate of the Late RT Hall (D.F.), Simon Lee Foundation (D.F.), Howard Hughes Medical Institute (C.E.S.), National Institutes of Health (J.G.S.), Leducq Foundation (J.G.S., C.E.S.) the Cancer Institute NSW (M.J.C.), and NSW Department of Health (M.J.C). J.I. is the recipient of a National Heart Foundation of Australia Future Leader Fellowship.

Author information

Correspondence to Diane Fatkin MD.

Ethics declarations

Disclosure

M.E.D., K.W., A.L.S., and B.L. are employed by Genome.One, a clinically accredited genetic testing provider that uses genome sequencing. The other authors declare no conflicts of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark